USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer-Reference-Cited by-同舟云学术

USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer

Published:2018-09-17 Issue:11 Volume:7 Page:5577-5588
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Fu Ying¹,Ma Gang¹,Liu Guolong¹,Li Bin²,Li Hui¹,Hao Xishan²,Liu Liren¹^ORCID

Affiliation:

1. Department of Gastrointestinal Cancer Biology; Tianjin Medical University Cancer Institute & Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy; Tianjin; Tianjin’s Clinical Research Center for Cancer; Tianjin 300060 China

2. Department of Gastrointestinal Surgery; Tianjin Medical University Cancer Institute & Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy; Tianjin; Tianjin’s Clinical Research Center for Cancer; Tianjin 300060 China

Funder

National Key R&D Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1770/fullpdf

Reference34 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016